Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
4.200
-0.240 (-5.41%)
At close: Nov 20, 2024, 4:00 PM
4.400
+0.200 (4.76%)
Pre-market: Nov 21, 2024, 7:32 AM EST
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $124.36 million as of November 21, 2024.
Market Cap
124.36M
Enterprise Value
123.62M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.20
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $124.36M, a decrease of -40.00%. That is a compound annual growth rate of -48.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 124.36M | -40.00% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 134.50M |
| Seer, Inc. | 134.44M |
| Inhibikase Therapeutics | 134.39M |
| Cardiff Oncology | 133.97M |
| Skye Bioscience | 131.67M |
| Cardiol Therapeutics | 130.94M |
| Adverum Biotechnologies | 130.02M |
| Candel Therapeutics | 129.58M |